In the fifth session of the webinar series, Dr. Christoph Conrad (Head of the Regulatory Support Unit, Berlin Institute of Health) will discuss key aspects of the regulatory landscape in preclinical research and Dr. Matthias Ocker (Head of Experimental Medicine, Tacalyx GmbH) will provide insights into the drug discovery process.